Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
67.8M
-
Number of holders
-
68
-
Total 13F shares, excl. options
-
49.9M
-
Shares change
-
-2.05M
-
Total reported value, excl. options
-
$61.9M
-
Value change
-
-$2.5M
-
Number of buys
-
36
-
Number of sells
-
-49
-
Price
-
$1.24
Significant Holders of Climb Bio, Inc. - Common Stock, par value $0.0001 per share (CLYM) as of Q2 2025
94 filings reported holding CLYM - Climb Bio, Inc. - Common Stock, par value $0.0001 per share as of Q2 2025.
Climb Bio, Inc. - Common Stock, par value $0.0001 per share (CLYM) has 68 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 49.9M shares
of 67.8M outstanding shares and own 73.64% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (31.4M shares), CANTOR FITZGERALD, L. P. (2.5M shares), CITIGROUP INC (1.61M shares), Affinity Asset Advisors, LLC (1.5M shares), VANGUARD GROUP INC (1.33M shares), Deep Track Capital, LP (1.04M shares), Kynam Capital Management, LP (1.03M shares), TANG CAPITAL MANAGEMENT LLC (1M shares), BlackRock, Inc. (878K shares), and DIADEMA PARTNERS LP (702K shares).
This table shows the top 68 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.